It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Gene delivery to primary human cells is a technology of critical interest to both life science research and therapeutic applications. However, poor efficiencies in gene transfer and undesirable safety profiles remain key limitations in advancing this technology. Here, we describe a materials-based approach whereby application of a bioresorbable mineral coating improves microparticle-based transfection of plasmid DNA lipoplexes in several primary human cell types. In the presence of these mineral-coated microparticles (MCMs), we observed up to 4-fold increases in transfection efficiency with simultaneous reductions in cytotoxicity. We identified mechanisms by which MCMs improve transfection, as well as coating compositions that improve transfection in three-dimensional cell constructs. The approach afforded efficient transfection in primary human fibroblasts as well as mesenchymal and embryonic stem cells for both two- and three-dimensional transfection strategies. This MCM-based transfection is an advancement in gene delivery technology, as it represents a non-viral approach that enables highly efficient, localized transfection and allows for transfection of three-dimensional cell constructs.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Department of Biomedical Engineering-University of Wisconsin-Madison, Madison, WI, USA
2 Department of Orthopedics and Rehabilitation-University of Wisconsin-Madison, Madison, WI, USA
3 Department of Bioengineering & Therapeutic Sciences-University of California, San Francisco, San Francisco, CA, USA; Roddenberry Center for Stem Cell Biology & Medicine-Gladstone Institutes, San Francisco, CA, USA
4 Department of Biomedical Engineering-University of Wisconsin-Madison, Madison, WI, USA; Department of Orthopedics and Rehabilitation-University of Wisconsin-Madison, Madison, WI, USA; The Materials Science Program-University of Wisconsin-Madison, Madison, WI, USA; The Stem Cell and Regenerative Medicine Center-University of Wisconsin-Madison, Madison, WI, USA